Randomized controlled trials of pharmacological treatments to prevent COPD exacerbations: applicability to real-life patients

Overview of attention for article published in BMC Pulmonary Medicine, July 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 53 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 9,371 followers.

RT @JuanMarcoFigue1: In this large cohort (1309 patients), a majority (>80%)of patients would not be eligible for enrolment into RCTs asses…

15 Jul 2019

Reply Repost Favourite

RT @JuanMarcoFigue1: In this large cohort (1309 patients), a majority (>80%)of patients would not be eligible for enrolment into RCTs asses…

15 Jul 2019

Reply Repost Favourite

In this large cohort (1309 patients), a majority (>80%)of patients would not be eligible for enrolment into RCTs assessing the efficacy of pharmaceutical intervention for #COPD #EPOC exacerbations. https://t.co/uvobbgdBUu @mabrito67 https://t.co/Zvzq8Zq

15 Jul 2019

Reply Repost Favourite

Randomized controlled trials of pharmacological treatments to prevent… https://t.co/kY7wOebttd #eprompt #respire

14 Jul 2019

Reply Repost Favourite